Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,021,764 | 3,931,594 | 3,510,772 | 4,604,979 | 4,247,147 |
| Marketable Securities | 4,619,269 | 4,417,409 | 5,114,308 | 5,373,094 | 4,441,484 |
| Receivables | 11,233,600 | 8,883,649 | 8,660,310 | 9,224,800 | 9,533,113 |
| Inventories | 6,937,132 | 6,901,575 | 6,505,254 | 6,365,087 | 5,487,370 |
| Other current assets | 75,955 | 91,403 | 163,996 | 121,220 | 140,156 |
| TOTAL | $26,887,720 | $24,225,630 | $23,954,640 | $25,689,180 | $23,849,270 |
| Non-Current Assets | |||||
| PPE Net | 11,157,640 | 10,844,440 | 10,639,220 | 11,049,230 | 10,483,600 |
| Investments And Advances | 1,445,658 | 1,690,335 | 1,627,832 | 1,906,063 | 1,933,948 |
| Intangibles | 28,189,061 | 27,855,474 | 25,531,454 | 26,425,127 | 26,834,991 |
| Other Non-Current Assets | 9,365,131 | 9,835,241 | 9,429,274 | 9,324,990 | 7,934,841 |
| TOTAL | $50,157,490 | $50,225,490 | $47,227,780 | $48,705,410 | $47,187,380 |
| Total Assets | $77,045,200 | $74,451,120 | $71,182,420 | $74,394,590 | $71,036,650 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,130,754 | 7,413,684 | 5,176,263 | 4,888,229 | 3,289,595 |
| Accounts payable and accrued liabilities | 19,725,250 | 17,468,050 | 17,332,770 | 20,115,710 | 18,980,250 |
| Accrued Expenses | 362,047 | 681,142 | 515,075 | 582,580 | 151,936 |
| Other current liabilities | 2,125,446 | 2,118,553 | 2,117,396 | 2,627,176 | 2,256,665 |
| TOTAL | $28,343,500 | $27,681,430 | $25,141,500 | $28,213,690 | $24,678,440 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,245,540 | 19,473,910 | 20,219,130 | 21,070,590 | 22,757,450 |
| Other Non-Current Liabilities | 11,884,265 | 11,293,946 | 11,556,391 | 12,149,084 | 12,861,574 |
| TOTAL | $32,727,310 | $31,545,410 | $32,299,100 | $33,693,160 | $36,092,500 |
| Total Liabilities | $61,070,810 | $59,226,840 | $57,440,600 | $61,906,840 | $60,770,950 |
| Shareholders' Equity | |||||
| Common Shares | 1,706,433 | 1,687,831 | 1,637,550 | 1,666,104 | 1,586,497 |
| Retained earnings | 8,882,820 | 8,035,978 | 6,869,694 | 5,396,595 | 3,052,858 |
| Other shareholders' equity | 1,017,782 | 1,180,726 | 1,044,731 | 1,170,105 | 1,574,723 |
| TOTAL | $15,974,390 | $15,224,280 | $13,741,820 | $12,487,740 | $10,265,710 |
| Total Liabilities And Equity | $77,045,200 | $74,451,120 | $71,182,420 | $74,394,580 | $71,036,660 |